| Product NDC: | 54473-578 |
| Proprietary Name: | Triple Antibiotic |
| Non Proprietary Name: | Bacitracin zinc and Neomycin and Polymyxin B sulfate |
| Active Ingredient(s): | 500; 3.5; 10000 [iU]/g; mg/g; [iU]/g & nbsp; Bacitracin zinc and Neomycin and Polymyxin B sulfate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54473-578 |
| Labeler Name: | Melaleuca, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part333B |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 19950701 |
| Package NDC: | 54473-578-01 |
| Package Description: | 14 g in 1 TUBE (54473-578-01) |
| NDC Code | 54473-578-01 |
| Proprietary Name | Triple Antibiotic |
| Package Description | 14 g in 1 TUBE (54473-578-01) |
| Product NDC | 54473-578 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Bacitracin zinc and Neomycin and Polymyxin B sulfate |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 19950701 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Melaleuca, Inc. |
| Substance Name | BACITRACIN ZINC; NEOMYCIN; POLYMYXIN B SULFATE |
| Strength Number | 500; 3.5; 10000 |
| Strength Unit | [iU]/g; mg/g; [iU]/g |
| Pharmaceutical Classes |